Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svrcek

Showing results (271-280 of 299) with videos related to

Pageof 30
Sort By:
Nature Communications|June 13, 2023
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Flore Delecourt, Benoit Schmauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal CancerMichael J Overman, Sara Lonardi, Ka Yeung Mark Wong, et al.
EMBO Reports|October 25, 2022
Loss of primary cilia promotes inflammation and carcinogenesisConception Paul, Ruizhi Tang, Ciro Longobardi, et al.
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
Gastroenterology|June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 18, 2018
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite InstabilityVincent Jonchere, Laetitia Marisa, Malorie Greene, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaR Nicolle, O Gayet, P Duconseil, et al.
Pageof 30

Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Nature Communications|June 13, 2023
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinomaCharlie Saillard, Flore Delecourt, Benoit Schmauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal CancerMichael J Overman, Sara Lonardi, Ka Yeung Mark Wong, et al.
EMBO Reports|October 25, 2022
Loss of primary cilia promotes inflammation and carcinogenesisConception Paul, Ruizhi Tang, Ciro Longobardi, et al.
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
Gastroenterology|June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 18, 2018
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite InstabilityVincent Jonchere, Laetitia Marisa, Malorie Greene, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaR Nicolle, O Gayet, P Duconseil, et al.
Pageof 30